Preparation method of 2-methyl-4-(1-methyl-1H-benzo [d] imidazole-2-yl) aniline

Through amino reaction in the presence of a base and Smiles rearrangement reaction, combined with water removal treatment, 2-methyl-4-(1-methyl-1H-benzo[d]imidazole-2-yl in the prior art was solved by combining the water removal treatment. ) The high cost and environmental pollution problems in the preparation of aniline have achieved efficient and green compound preparation and are suitable for industrial production.

CN119059980AActive Publication Date: 2024-12-03SHANGHAI INST OF PHARMA IND CO LTD +1
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202310634648.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-31
Publication Date
2024-12-03
Estimated Expiration
2043-05-31

AI Technical Summary

Technical Problem

In the prior art, the preparation method of 2-methyl-4-(1-methyl-1H-benzo[d]imidazole-2-yl)aniline has problems such as high cost, environmental pollution and unsuitable for industrial production, especially Due to the use of expensive reagents, high temperature reactions and the generation of large amounts of waste acid wastewater.

Method used

The amino reaction and Smiles rearrangement reaction in the presence of a base are carried out, combined with physical or chemical water removal treatment, and the compound is prepared by optimizing the reaction conditions and steps, avoiding the use of dangerous reagents and high temperature conditions, and using commercially available Inexpensive and easy to obtain raw materials and reagents.

Benefits of technology

It achieves high yield preparation of compounds, reduces costs, reduces environmental pollution, is suitable for large-scale production, and avoids column chromatography purification, which improves the industrial application value of the process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119059980A_ABST
    Figure CN119059980A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of 2-methyl-4-(1-methyl-1H-benzo [d] imidazole-2-yl) aniline, and relates to a preparation method of 2-methyl-4-(1-methyl-1H-benzo [d] imidazole-2-yl) aniline. Specifically, the invention provides a preparation method of a compound 31, which comprises the following steps: in a solvent, in the presence of alkali, a compound 30 is subjected to an amino reaction as shown in the following formula to obtain the compound 31, and the alkali is alkali metal carbonate. According to the method, raw materials and reagents are low in cost and easy to obtain, and the telmisartan key intermediate can be prepared at high yield. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a method for preparing 2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)aniline. Background Art

[0002] Telmisartan was developed by Schering-Plough of Germany. It is a highly selective angiotensin II receptor antagonist. It was approved by the FDA as an effective antihypertensive drug in 1998 and was launched in the United States the following year. It entered the domestic market in 2001. Currently, many domestic pharmaceutical companies are developing and producing Telmisartan.

[0003]

[0004] Telmisartan is an antihypertensive drug and a sartan drug approved by the FDA. It belongs to angiotensin II receptor antagonists and has the advantages of maintaining the normal regulatory function of the cardiovascular system and reducing organ damage caused by hypertension. Compared with other antihypertensive drugs, telmisartan has better efficacy and lower toxicity and can be used to control blood pressure balance. The efficient and green synthesis of 2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)aniline is the key to the production of telmisartan.

[0005] The construction of the methyl-substituted benzimidazole ring in 2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)aniline is a key difficulty, but the methods currently provided in the literature are costly and environmentally polluting, and there is a lack of a method to construct the benzimidazole structure from cheap and readily available starting materials and green and environmentally friendly reagents.

[0006] Route 1: Organic Process Research & Development, 2007, 11(1), 81-85

[0007]

[0008] When constructing the propyl-substituted benzimidazole ring (compound 6), sulfuric acid and fuming nitric acid are used for nitration. The reaction is violently exothermic and poses a great safety hazard. In addition, the strong acid is highly corrosive to the equipment. Post-processing produces a large amount of waste acid and wastewater, which is harmful to the environment.

[0009] When constructing the methyl-substituted benzimidazole ring (compound 9), polyphosphoric acid (2.0 equiv) was used as a solvent and dehydrating agent. However, polyphosphoric acid has poor fluidity and is difficult to feed. The reaction needs to be carried out at a high temperature of 150°C for 4-5 hours, which consumes a lot of energy and is highly corrosive to production equipment. In addition, a large amount of waste acid and wastewater will be generated during the post-treatment process, which poses a great environmental hazard.

[0010] Route 2 CN113024469 A:

[0011]

[0012] When constructing 2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)aniline, the Duff reaction was used. The catalyst trifluoroacetic acid reagent of the reaction is expensive and used in large quantities. A large amount of waste acid and wastewater will be generated during the post-treatment process, which is very harmful to the environment.

[0013] Route 3 CN103755641A:

[0014]

[0015] The expensive and hard-to-get 4-amino-3-methylbenzoic acid (20) was selected as the raw material, and the auxiliary material triethyl orthobutyrate was relatively expensive and costly; hydrosulfite was used to reduce the nitro group, and the reaction solvent was water, which would release heat violently during the reaction and produce toxic and harmful sulfur dioxide and hydrogen sulfide gases. The fourth step reaction used thionyl chloride, which had a strong pungent odor, and was very harmful to the environment and human body.

[0016] The above method has the following disadvantages: the raw materials are expensive, high temperature reaction conditions are required, the operation is cumbersome, separation and purification by silica gel chromatography is required, a large amount of waste acid and waste water is generated, and it is not suitable for industrial production.

[0017] In view of the above shortcomings, it is necessary to design a new efficient and practical synthetic route to optimize the synthesis of telmisartan intermediate 2-methyl-4-(1-methyl-1H-benzimidazol-2-yl)amine (1). Summary of the invention

[0018] The technical problem to be solved by the present invention is to solve the problem of the shortcomings of the preparation method of 2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)aniline (Compound 1) in the prior art; and to provide a preparation method of 2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)aniline, wherein the raw materials and reagents of the method are cheap and readily available, and the key intermediate of telmisartan can be prepared in high yield. No hazardous reagents are used in the preparation process, and the method is a green and environmentally friendly process with little environmental pollution and suitable for large-scale preparation.

[0019] The present invention solves the above technical problems through the following technical solutions.

[0020] The present invention provides a preparation method 1 of compound 31, which comprises the following steps: in a solvent, in the presence of a base, compound 30 undergoes an amino reaction as shown in the following formula to obtain compound 31, wherein the base is an alkali metal carbonate;

[0021]

[0022] The solvent may be a conventional solvent for such reactions in the art, preferably a high boiling point polar solvent, for example, one or more selected from amide solvents, sulfoxide solvents and alkanone solvents. The amide solvent may be N,N-dimethylformamide (DMF); the sulfoxide solvent may be dimethyl sulfoxide (DMSO); the alkanone solvent may be N-methylpyrrolidone (NMP). The solvent is preferably DMF, more preferably anhydrous DMF.

[0023] The preparation method 1 of the compound 31 comprises a Smiles rearrangement reaction and a hydrolysis.

[0024] The amount of the solvent used is not limited as long as it does not affect the reaction; for example, the mass ratio of the compound 30 to the solvent may be 1:(1-20), such as 1:3.5.

[0025] The base is preferably potassium carbonate and / or sodium carbonate, and more preferably anhydrous potassium carbonate.

[0026] The molar ratio of the compound 30 to the base may be (1-3):1, for example 1.14:1.

[0027] The preparation method of the compound 31 further comprises removing water.

[0028] The dehydration includes physical dehydration and chemical dehydration.

[0029] The physical dehydration is to add toluene to the reaction system to remove water in the reaction system by azeotropy. Further, the azeotropy is preferably reduced pressure azeotropy.

[0030] The temperature of the physical water removal can be a conventional temperature for this type of method, such as 60-90°C, and for example 80°C.

[0031] The chemical dehydration is to add an ester solvent or a nitrile solvent to the reaction system (the ester solvent or the nitrile solvent consumes a small amount of water in the reaction system by hydrolysis). The ester solvent is preferably methyl formate, ethyl acetate or methyl acetate, more preferably anhydrous methyl formate, anhydrous ethyl acetate or anhydrous methyl acetate. The nitrile solvent is preferably anhydrous acetonitrile.

[0032] The temperature of the chemical dehydration can be a conventional temperature for this type of method, such as 60-90°C, and for example 80°C.

[0033] The temperature of the Smiles rearrangement reaction can be a conventional temperature for such reactions in the art, such as 115°C to 180°C, and in the present invention, it is preferably 140°C to 160°C, such as 150°C.

[0034] The progress of the Smiles rearrangement reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR), and the reaction endpoint is generally taken as the disappearance or no-reaction of compound 30. The reaction time can be 1-24 hours, such as 3-6 hours, and for example 4.5 hours.

[0035] The hydrolysis reaction is to add water to the reaction system after the Smiles rearrangement reaction is completed.

[0036] The reaction temperature of the hydrolysis reaction is 115°C to 180°C, preferably 140°C to 160°C, such as 150°C.

[0037] In the hydrolysis reaction, the molar ratio of water to compound 30 is greater than or equal to 1, and preferably the molar ratio of water to compound 30 is 1.67:1.

[0038] The preparation method 1 of the compound 31 may further include post-treatment, and the post-treatment operation may be a conventional post-treatment operation in this type of preparation method in the art, which includes the following steps: after the reaction is completed, cooling, acidification, alkalization, extraction, and concentration.

[0039] The acidification may be a conventional acidification method in this type of reaction in the art, for example, the acidification acid is hydrochloric acid, preferably 2M hydrochloric acid, and the molar ratio of the compound 30 to the acidification acid is 1:1.6.

[0040] The alkalization can be a conventional alkalization method in this type of reaction in the art, the alkalization base is NaOH, preferably a 15% NaOH aqueous solution, and the alkalization pH is 8-9. The extraction can be a conventional extraction method in this type of reaction in the art, and the extraction solvent can be ethyl acetate. The concentration can be a conventional concentration method in this type of reaction in the art, such as reduced pressure concentration.

[0041] The post-treatment operation may also include the following steps: after the reaction is completed, cooling, extraction, washing, and concentration. The extraction may be a conventional extraction method in this type of reaction in the art, such as extraction with a solvent (such as ethyl acetate). The washing may be a conventional washing method in this type of reaction in the art, such as washing with a washing solvent of NaOH, preferably 10% NaOH aqueous solution for 2 times. The concentration may be a conventional concentration method in this type of reaction in the art, such as concentration under reduced pressure.

[0042] In a certain embodiment, the raw materials and reagents of the preparation method 1 of the compound 31 consist of the following components: the solvent, the base and the compound 30.

[0043] The preparation method 1 of the compound 31 also includes a preparation method of the compound 30, which comprises the following steps: in a solvent, in the presence of a base and a catalyst, compound 28 and compound 29 undergo an alkylation reaction to obtain compound 30; the catalyst is a halogen metal salt and / or a phase transfer catalyst;

[0044]

[0045] The solvent may be a conventional solvent for such reactions in the art, preferably a polar aprotic solvent, such as one or more selected from amide solvents, sulfoxide solvents, nitrile solvents, ketone solvents and ester solvents. The amide solvent may be N,N-dimethylformamide (DMF); the sulfoxide solvent may be dimethyl sulfoxide (DMSO); the nitrile solvent may be acetonitrile; the ketone solvent may be acetone; the ester solvent may be ethyl acetate. The solvent is preferably DMF.

[0046] The amount of the solvent used is not limited as long as it does not affect the reaction; for example, the mass ratio of the compound 28 to the solvent may be 1:(1-10), such as 1:3.55.

[0047] The base can be a conventional base for this type of reaction in the art, such as alkali metal carbonates (such as potassium carbonate and / or sodium carbonate), alkali metal hydroxides (such as sodium hydroxide and / or potassium hydroxide) and organic bases (such as triethylamine (TEA)), and the base is further preferably anhydrous potassium carbonate.

[0048] The molar ratio of the compound 28 to the base may be 1:(1-3), for example 1:1.1.

[0049] The halogen metal salt may be an alkali metal salt, preferably potassium iodide and / or potassium bromide, such as potassium iodide.

[0050] The molar ratio of the compound 28 to the halogen metal salt may be 1:(0.05-0.3), for example 1:0.05.

[0051] The phase transfer catalyst may be a conventional phase transfer catalyst for this type of reaction in the art, such as a quaternary ammonium salt (such as tetrabutylammonium bromide (TBAB) and / or tetrabutylammonium fluoride (TBAF)), more preferably tetrabutylammonium bromide.

[0052] The molar ratio of the compound 28 to the phase transfer catalyst may be 1:(0.05-0.3), for example 1:0.1.

[0053] The molar ratio of the compound 28 to the compound 29 may be 1:(1-2.5), for example 1:1.03.

[0054] The temperature of the alkylation reaction can be a conventional temperature for such reactions in the art, such as 70°C to 130°C, and in the present invention, it is preferably 80°C to 110°C, such as 110°C.

[0055] The progress of the alkylation reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR), and the reaction endpoint is generally when compound 28 disappears or no longer reacts. The reaction time can be 1-24 hours, such as 4 hours.

[0056] The preparation method of the compound 30 may further include the following steps: after the alkylation reaction is completed, cooling, quenching, and separation. The quenching may be a conventional quenching method in this type of reaction in the art, such as water quenching, and further the mass ratio of the water to the compound 28 is 5:1. The separation may be a conventional separation method in this type of compound in the art, such as filtration.

[0057] The post-treatment may also be performed by extraction after quenching, and the extraction may be a conventional extraction method in this type of reaction in the art, for example, the extraction solvent is dichloromethane.

[0058] In a certain embodiment, the raw materials and reagents for the preparation method of the compound 30 consist of the following components: the solvent, the base, the catalyst, the phase transfer catalyst, the compound 28 and the compound 29.

[0059] The present invention also provides a preparation method 2 of compound 31, which comprises the following steps: in a solvent, in the presence of a base and a catalyst, compound 28 reacts with compound 29 to obtain compound 31, wherein the base is an alkali metal carbonate; the catalyst is a halogen metal salt and / or a phase transfer catalyst;

[0060]

[0061] Specifically, the preparation method 2 of compound 31 comprises the following steps: compound 28 is subjected to step 1 to obtain compound 30, and then subjected to step 2 to obtain compound 31.

[0062]

[0063] The solvent may be a conventional solvent for such reactions in the art, preferably a polar aprotic solvent, such as one or more selected from amide solvents, sulfoxide solvents, nitrile solvents, ketone solvents and ester solvents. The amide solvent may be N,N-dimethylformamide (DMF); the sulfoxide solvent may be dimethyl sulfoxide (DMSO); the nitrile solvent may be acetonitrile; the ketone solvent may be acetone; the ester solvent may be ethyl acetate. The solvent is preferably DMF.

[0064] The amount of the solvent used is not limited as long as it does not affect the reaction; for example, the mass ratio of the compound 28 to the solvent may be 1:(1-10), such as 1:5.

[0065] The base can be a conventional base for this type of reaction in the art, such as alkali metal carbonates (such as potassium carbonate and / or sodium carbonate), alkali metal hydroxides (such as sodium hydroxide and / or potassium hydroxide) and organic bases (such as triethylamine (TEA)), and the base is further preferably anhydrous potassium carbonate.

[0066] The molar ratio of the compound 28 to the base may be 1:(1-3), for example 1:1.2.

[0067] The halogen metal salt may be an alkali metal salt, preferably potassium iodide and / or potassium bromide, such as potassium iodide.

[0068] The molar ratio of the compound 28 to the catalyst may be 1:(0.05-0.3), for example 1:0.1.

[0069] The molar ratio of the compound 28 to the compound 29 may be 1:(1-2.5), for example 1:1.03.

[0070] The reaction temperature of step 1 can be a conventional temperature for such reactions in the art, such as 70°C to 130°C, and in the present invention, it is preferably 80°C to 110°C, such as 110°C.

[0071] The reaction progress of step 1 can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR), and the disappearance or no-reaction of compound 28 is generally regarded as the reaction endpoint. The reaction time can be 1-24 hours, for example, 2 hours.

[0072] Between step 1 and step 2, a water removal operation is further included.

[0073] The dehydration includes physical dehydration and chemical dehydration.

[0074] The physical dehydration is to add toluene to the reaction system to remove water in the reaction system by azeotropy. It is further preferred to remove water by azeotropy under reduced pressure. The pressure of the azeotropy under reduced pressure can be -0.08Mpa.

[0075] The temperature of the physical water removal can be a conventional temperature for this type of method, such as 60-90°C, and for example 80°C.

[0076] The chemical dehydration is to add an ester solvent or a nitrile solvent to the reaction system. The ester solvent is preferably methyl formate, ethyl acetate or methyl acetate, more preferably anhydrous methyl formate, anhydrous ethyl acetate or anhydrous methyl acetate. The nitrile solvent is preferably anhydrous acetonitrile.

[0077] The temperature of the chemical dehydration can be a conventional temperature for this type of method, such as 60-90°C, and for example 80°C.

[0078] The reaction temperature of step 2 is 135°C to 180°C, preferably 140°C to 160°C, such as 150°C.

[0079] The reaction progress of step 2 can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR), and the reaction endpoint is generally taken as the disappearance or no-reaction of compound 30. The reaction time can be 1-24 hours, such as 3-6 hours, and for example 5 hours.

[0080] Preferably, after step 2, water is further added, and the molar ratio of water to compound 28 is greater than or equal to 1, and preferably the molar ratio of water to compound 28 is 2.08:1.

[0081] The preparation method 2 of the compound 31 may further include post-treatment, and the post-treatment operation may be a conventional post-treatment operation in this type of preparation method in the art, which includes the following steps: after the reaction is completed, cooling, acidifying, alkalizing, and filtering.

[0082] The acidification may be a conventional acidification method in this type of reaction in the art, for example, the acidification acid is hydrochloric acid, preferably 2M hydrochloric acid, and the molar ratio of the compound 28 to the hydrochloric acid used is 1:2.

[0083] The alkalization can be a conventional alkalization method in this type of reaction in the art, for example, the alkalization base is NaOH, preferably 15% NaOH aqueous solution, and the alkalization pH is 8-9. The filtration can be a conventional filtration method in this type of reaction in the art, such as suction filtration.

[0084] In a certain embodiment, the raw materials and reagents of the preparation method 2 of the compound 31 consist of the following components: the solvent, the base, the catalyst and the compound 28.

[0085] The present invention also provides a method for preparing compound 1, which comprises the following steps: in a solvent, compound 31 and N-methyl-o-phenylenediamine or N-methyl-o-phenylenediamine salt undergo a ring-closing reaction to obtain compound 1;

[0086]

[0087] The solvent may be a conventional solvent for such reactions in the art, for example, one or more selected from amide solvents, sulfoxide solvents, alkanone solvents, alcohol solvents, nitrile solvents, ester solvents, aromatic hydrocarbon solvents, halogenated hydrocarbon solvents and ether solvents. The amide solvent may be N,N-dimethylformamide (DMF); the sulfoxide solvent may be dimethyl sulfoxide (DMSO); the alkanone solvent may be N-methylpyrrolidone (NMP) and / or acetone; the alcohol solvent may be ethanol; the nitrile solvent may be acetonitrile; the ester solvent may be ethyl acetate; the aromatic hydrocarbon solvent may be toluene; the halogenated hydrocarbon solvent may be 1,2-dichloroethane; the ether solvent may be tetrahydrofuran. The solvent is preferably DMF.

[0088] The amount of the solvent used is not limited as long as it does not affect the reaction; for example, the mass ratio of the compound 31 to the solvent may be 1:(1-10), such as 1:5.

[0089] The N-methyl-o-phenylenediamine salt is further preferably N-methyl-o-phenylenediamine hydrochloride.

[0090] The molar ratio of the compound 31 to the N-methyl-o-phenylenediamine or its salt may be 1:(0.8-1.2), for example 1:1.

[0091] The ring-closing reaction further comprises a base, and the base can be a conventional base for this type of reaction in the art, such as an organic base (such as triethylamine) and / or an inorganic base; more preferably triethylamine.

[0092] The molar ratio of the N-methyl-o-phenylenediamine or its salt to the base can be 1:(1-3), for example 1:2.05.

[0093] The ring-closing reaction may be further carried out in the presence of an additive, which may be a conventional additive for such reactions in the art (the additive makes the reaction more efficient), such as an alkali metal bisulfate (such as sodium bisulfite and / or sodium bisulfite), more preferably sodium bisulfite.

[0094] The molar ratio of the compound 31 to the additive may be 1:(1-2), for example 1:1.2.

[0095] The temperature of the ring-closure reaction can be a conventional temperature for such reactions in the art, such as 60°C to 130°C, and in the present invention, it is preferably 70°C to 130°C, such as 70, 80, 90, 110 or 130°C, preferably 130°C.

[0096] The progress of the ring-closing reaction can be monitored by conventional monitoring methods in the art (such as TLC, HPLC or NMR), and the reaction endpoint is generally taken as the disappearance or no-reaction of compound 31. The reaction time can be 1-24 hours, such as 3-6 hours, and for example 5 hours.

[0097] The preparation method of compound 1 may further include post-treatment, and the post-treatment operation may be a conventional post-treatment operation in the preparation method of the same type in the art, which includes the following steps: after the ring-closing reaction is completed, cooling, quenching, extraction, concentration, and purification. The quenching may be a conventional quenching method in the reaction of the same type in the art, such as water quenching. The extraction may be a conventional extraction method in the reaction of the same type in the art, such as the extraction solvent is dichloromethane. The concentration may be a conventional concentration method in the reaction of the same type in the art, such as reduced pressure concentration.

[0098] Purification can be performed by conventional purification methods for compounds of this type in the art, such as recrystallization (V 乙醇 :V 环己烷 =1:5).

[0099] In one embodiment, the raw materials and reagents for the preparation method of compound 1 consist of the following components: a solvent, compound 31 and N-methyl-o-phenylenediamine or a salt thereof.

[0100] In the preparation method of the compound 1, the following steps may be further included:

[0101] Preparation method 1 of compound 31 comprises the following steps: in a solvent, in the presence of a base, compound 30 undergoes an amino reaction as shown in the following formula to obtain compound 31, wherein the base is an alkali metal carbonate;

[0102]

[0103] Alternatively, the preparation method 2 of compound 31 comprises the following steps: in a solvent, in the presence of a base and a catalyst, compound 28 reacts with compound 29 to obtain compound 31, wherein the base is an alkali metal carbonate; the catalyst is a halogen metal salt and / or a phase transfer catalyst;

[0104]

[0105] Preferably, the reaction conditions and steps of the preparation method of compound 31 are as described above.

[0106] Preferably, the reaction conditions and steps described in method 2 for preparing compound 31 are as described above.

[0107] The present invention provides a method for preparing compound 30, which comprises the following steps: in a solvent, in the presence of a base, a catalyst and a phase transfer catalyst, compound 28 undergoes an alkylation reaction with chloroacetamide to obtain compound 30;

[0108]

[0109] The reaction conditions and steps of the preparation method of compound 30 are the same as those described in the previous alkylation reaction.

[0110] The present invention also provides a compound 30, the structure of which is shown below:

[0111]

[0112] Without violating the common sense in the art, the above-mentioned preferred conditions can be arbitrarily combined to obtain the preferred embodiments of the present invention.

[0113] The reagents and raw materials used in the present invention are commercially available.

[0114] The positive progress of the present invention is that the route for preparing compound 1 of the present invention has one or more of the following advantages:

[0115] (1) The starting materials are cheap and readily available, and the route preparation cost is low;

[0116] (2) The preparation of compound 1 does not require the use of catalyst PPA and has no side reactions. The yield can reach 95%, which is much higher than the ring-closing reaction yield in other literatures and is green and environmentally friendly.

[0117] (3) The route of the present invention can avoid the use of column chromatography to purify the product in each step, which is conducive to industrialization.

[0118] The method for preparing compound 30 from compound 28 improves the yield compared with the similar structure in the prior art.

[0119] The method for preparing compound 31 from compound 30 improves the yield compared with similar structures in the prior art, and further better avoids the generation of high content of by-products.

[0120] Compound 31 can also be prepared from compound 28 via a one-pot process, which can further save reaction steps and improve the industrial application value of the process.

[0121] The method for preparing compound 1 from compound 31 has the advantages of fewer impurities and complete conversion compared to this type of cyclization method. DETAILED DESCRIPTION

[0122] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The experimental methods in the following examples without specifying specific conditions are carried out according to conventional methods and conditions, or selected according to the product specifications.

[0123] A method for preparing telmisartan intermediate 2-methyl-4-(1-methyl-1H-benzimidazol-2-yl)amine (1), the specific route is as follows:

[0124]

[0125] Example 1: Preparation of Compound 27

[0126] Compound 26 (85.52 g, 600 mmol) was dissolved in DMF (56.28 g, 770 mmol). POCl3 (123.42 g, 805 mmol) was added dropwise at 0°C within 40 min. After the addition was completed, stirring was continued for 30 min. The reaction system was heated to 70°C and stirred for 6 h. After the reaction was completed, the temperature was lowered to 25°C, 425 ml of water was slowly added, and the mixture was stirred under ice bath for 1 h. Extracted with ethyl acetate and concentrated under reduced pressure to obtain a colorless liquid (74.02 g, 82.15%).

[0127] Structural characterization data: 1 HNMR (400MHz, CDCl3) δ2.27(s,3H),3.92(s,3H),6.90(d,1H),7.7(m,2H),9.86(s,1H);

[0128] ESI-MS (m / z): 150.1 [M+H] + .

[0129] Example 2: Preparation of Compound 28

[0130] Compound 27 (75.09 g, 500 mmol) and anhydrous aluminum chloride (120.14 g, 800 mmol) were added to 1,2-dichloromethane (190 g) and reacted at 65°C for 12 h. After the reaction was completed, the mixture was cooled to room temperature, and the reaction solution was slowly added dropwise to water (200 ml) in an ice bath. After stirring for 30 min, dichloromethane (200 g × 3) was added for extraction, the organic phases were combined, and the organic phases were washed 3 times with 10% NaOH (100 g × 3), and the organic phases were concentrated under reduced pressure to recover the raw material 27, the aqueous phases were combined, and the pH of the aqueous phase was adjusted to 7 with hydrochloric acid. The product was precipitated, filtered, and vacuum dried to obtain a purple powder 3-methyl-4-hydroxybenzaldehyde 28 (60.05 g, 88.21%).

[0131] Structural characterization data: 1H NMR (400MHz, CDCl3) δ2.34(s,3H,),6.95(d,J=8.0Hz,1H),7.67(dd,J=1.6,8.0Hz,1H),7.72(s,1H),9.85(s,1H);

[0132] ESI-MS (m / z, %): 137.1 [M+H] + .

[0133] Example 3: Preparation of Compound 30

[0134] 28 (68.07 g, 500 mmol), chloroacetamide (47.92 g, 512.5 mmol), catalyst potassium iodide (4.15 g, 25 mmol), phase transfer catalyst TBAB (16.11 g, 50 mmol) were added to DMF (241.50 g), 76.01 g anhydrous potassium carbonate (550 mmol) was added, the temperature was raised to 100°C, and the reaction was carried out for 4 h. After the reaction was completed, it was cooled to room temperature, 340.35 g water was added, stirred for 5 h, filtered, the filter cake was washed with water, and dried to obtain a white powder (92.21 g, 95.46%).

[0135] Structural Characterization Data: 1 HNMR(400MHz, CDCl3)9.82(1H,s),7.76–7.60(2H,m),7.19(1H,s),6.85(1H,d,J=8.7 Hz),6.39(1H,s),5.73(1H,s),4.53(2H,s),2.29(3H,s).ESI-MS(m / z,%):194.1[M+H] + .

[0136] Example 4: Preparation of Compound 31

[0137] 30 (96.57 g, 500 mmol) and anhydrous potassium carbonate (60.80 g, 440 mmol) were added to DMF (340 g). After the addition of the materials, 1) toluene (20 mL × 3) was added to remove water (-0.08 MPa) by azeotropic distillation under reduced pressure at 80 ° C; 2) methyl formate (20 mL) was added to react at 80 ° C to consume water for 2 h. After the naturally existing water in the system was properly handled. The temperature was raised to 150 ° C, reacted for 4.5 h, 15 g of water was added dropwise, and the stirring reaction was continued for 2 h. After the reaction was completed, 1) cooled to room temperature, 2M hydrochloric acid (400 ml) was added, stirred at room temperature for 30 min, filtered, and the pH of the filtrate was adjusted to 8-9 with 15% NaOH aqueous solution, extracted with 150 ml of ethyl acetate, and concentrated under reduced pressure to obtain a yellow powder (56.92 g, 84.24%). 2) Cool to room temperature, add water (500 g), extract with ethyl acetate (200 mL × 3), combine the organic phases and wash twice with 10% NaOH aqueous solution (50 mL × 2). Concentrate the organic phase under reduced pressure to obtain a yellow powder (58.36 g, 86.38%)

[0138] Structural characterization data: 1 H NMR (400MHz, CDCl3) δ2.24 (s, 3H,), 6.34 (d, J = 10.0Hz, 1H), 7.58 (m, 2H), 9.76 (s, 1H);

[0139] ESI-MS (m / z, %): 137.1 [M+H] + .

[0140] Example 5: Preparation of compound 31 (one-pot method):

[0141] Compound 28 (54.06 g, 400 mmol), chloroacetamide (38.34 g, 410 mmol), anhydrous potassium carbonate (66.34 g, 480 mmol), potassium iodide (6.64 g, 40 mmol) were added to DMF (270.30 g), heated to 110°C, and reacted for 2 h. After the reaction was completed, 1) toluene (20 mL × 2) was added to remove water by azeotropic distillation under reduced pressure; 2) methyl formate (20 mL) was added to react at 80°C to consume water for 2 h. After the natural water in the system was properly handled. The temperature was raised to 150°C, reacted for 5 h, 15 g of water was added dropwise, the reaction was continued with stirring for 2 h, cooled, 400 ml of 2M hydrochloric acid was added, and the reaction was stirred at room temperature for 30 min. Filtered by suction, the filtrate was taken, the pH was adjusted to 8-9 with 15% NaOH aqueous solution, filtered by suction, and a yellow powder (42.83 g, 79.24%) was obtained.

[0142] Structural characterization data: 1H NMR (400MHz, CDCl3) δ6.72 (d, J = 7.5Hz, 1H), 7.50 (d, J = 6.0Hz, 2H), 2.15 (s, 3H), 6.10 (s, 2H), 9.62 (s, 1H);

[0143] ESI-MS (m / z, %): 136.1 [M+H] + .

[0144] Example 6: Preparation of Compound 1

[0145] 31 (54.06 g, 400 mmol), sodium bisulfite (49.93 g, 480 mmol), triethylamine (82.97 g, 820 mmol) were added to the solvent (270.3 g) shown in the following table, N-methyl-o-phenylenediamine hydrochloride (78.03 g, 400 mmol) was slowly added at room temperature, the temperature was raised to 130°C, the reaction was carried out for 5 h, water and dichloromethane were added to the system, the aqueous phase was extracted with dichloromethane for 3 times, the organic phase was concentrated under reduced pressure, and recrystallized with a mixed solvent of ethanol and cyclohexane (volume ratio 1:5) to obtain a brown powder. The yield is shown in the following table:

[0146]

[0147]

[0148] Structural characterization data: 1 H NMR(400MHz,DMSO-d6)δ7.59–7.57(m,1H),7.53–7.51(m,1H),7.46(s,1H),7 .41(dd,J=8.4,1.6Hz,1H),7.24-7.15(m,2H),6.73(d,J=8.4Hz,1H),5.36(br s,2H),3.84(s,3H),2.14(s,3H); ESI-MS(m / z,%):238.1[M+H] + .

Claims

1. A method 1 for preparing compound 31, characterized in that: The method comprises the following steps: in a solvent, in the presence of a base, compound 30 undergoes an amino reaction as shown in the following formula to obtain compound 31, wherein the base is an alkali metal carbonate; 2. The preparation method 1 of compound 31 according to claim 1, characterized in that: It meets one or more of the following conditions: (1) The solvent is a high boiling point polar solvent, for example, one or more selected from amide solvents, sulfoxide solvents and alkanone solvents; the amide solvent may be N,N-dimethylformamide; the sulfoxide solvent may be dimethyl sulfoxide; the alkanone solvent may be N-methylpyrrolidone; the solvent is preferably DMF, more preferably anhydrous DMF; (2) The mass ratio of the compound 30 to the solvent is 1:(1-20), for example 1:3.5; (3) The base is potassium carbonate and / or sodium carbonate, more preferably anhydrous potassium carbonate; (4) The molar ratio of the compound 30 to the base is (1-3):1, for example 1.14:1; (5) The preparation method 1 of compound 31 comprises Smiles rearrangement reaction and hydrolysis; (6) The preparation method of compound 31 further comprises dehydration; further, the dehydration comprises physical dehydration and chemical dehydration; (7) The preparation method 1 of compound 31 also includes post-treatment, and the post-treatment operation includes the following steps: cooling, acidification, alkalization, extraction, and concentration after the reaction is completed; (8) The raw materials and reagents of the preparation method 1 of the compound 31 consist of the following components: the solvent, the base and the compound 30.

3. The preparation method 1 of compound 31 according to claim 2, characterized in that: It meets one or more of the following conditions: (1) The physical dehydration is to add toluene to the reaction system to azeotropically remove water in the reaction system; further, the azeotropic is a reduced pressure azeotropic; the pressure of the reduced pressure azeotropic can be -0.08Mpa; (2) The temperature of the physical dehydration is 60-90° C., for example, 80° C.; (3) The chemical dehydration is to add an ester solvent or a nitrile solvent to the reaction system; the ester solvent is preferably methyl formate, ethyl acetate or methyl acetate, more preferably anhydrous methyl formate, anhydrous ethyl acetate or anhydrous methyl acetate; the nitrile solvent is preferably anhydrous acetonitrile; (4) The temperature of the chemical dehydration is 60-90° C., for example 80° C.; (5) The temperature of the Smiles rearrangement reaction is 115°C to 180°C, preferably 140°C to 160°C, for example 150°C; (6) The reaction time of the Smiles rearrangement reaction is 1-24 hours, for example 3-6 hours, for example 4.5 hours; (7) The hydrolysis reaction is performed by adding water to the reaction system after the Smiles rearrangement reaction is completed; (8) The reaction temperature of the hydrolysis reaction is 115°C to 180°C, preferably 140°C to 160°C, for example 150°C; (9) In the hydrolysis reaction, the molar ratio of water to compound 30 is greater than or equal to 1, preferably the molar ratio of water to compound 30 is 1.67:1; (10) The acidified acid is hydrochloric acid, preferably 2M hydrochloric acid; (11) The molar ratio of the compound 30 to the acidified acid is 1:1.6; (12) The alkalizing base is NaOH, preferably a 15% NaOH aqueous solution, (13) The alkalinization pH is 8-9; (14) The extraction solvent is ethyl acetate; and The concentration described in (15) is concentration under reduced pressure.

4. The preparation method 1 of compound 31 according to claim 1, characterized in that: The preparation method 1 of the compound 31 also includes a preparation method of the compound 30, which comprises the following steps: in a solvent, in the presence of a base and a catalyst, compound 28 and compound 29 undergo an alkylation reaction to obtain compound 30; the catalyst is a halogen metal salt and / or a phase transfer catalyst; 5. The preparation method 1 of compound 31 according to claim 4, characterized in that: It meets one or more of the following conditions: (1) The solvent is a polar aprotic solvent, for example, one or more selected from amide solvents, sulfoxide solvents, nitrile solvents, ketone solvents and ester solvents; the amide solvent may be N,N-dimethylformamide; the sulfoxide solvent may be dimethyl sulfoxide; the nitrile solvent may be acetonitrile; the ketone solvent may be acetone; the ester solvent may be ethyl acetate; the solvent is preferably DMF; (2) The mass ratio of the compound 28 to the solvent is 1:(1-10), for example 1:3.55; (3) The base is an alkali metal carbonate, an alkali metal hydroxide and an organic base. The alkali metal carbonate may be potassium carbonate and / or sodium carbonate; the alkali metal hydroxide may be sodium hydroxide and / or potassium hydroxide; the organic base may be triethylamine; and the base is more preferably anhydrous potassium carbonate; (4) The molar ratio of the compound 28 to the base is 1:(1-3), for example 1:1.1; (5) The halogen metal salt is an alkali metal salt, preferably potassium iodide and / or potassium bromide, such as potassium iodide; (6) The molar ratio of the compound 28 to the halogen metal salt is 1:(0.05-0.3), for example 1:0.05; (7) The phase transfer catalyst is a quaternary ammonium salt, and the quaternary ammonium salt may be tetrabutylammonium bromide and / or tetrabutylammonium fluoride; more preferably, tetrabutylammonium bromide; (8) The molar ratio of the compound 28 to the phase transfer catalyst is 1:(0.05-0.3), for example 1:0.1; (9) The molar ratio of the compound 28 to the compound 29 is 1:(1-2.5), for example 1:1.03; (10) The temperature of the alkylation reaction is 70°C to 130°C, preferably 80°C to 110°C, for example 110°C; (11) The reaction time of the alkylation reaction is 1-24 hours, for example 4 hours; (12) The preparation method of the compound 30 may further comprise the following steps: after the alkylation reaction is completed, cooling, quenching, and separation; the quenching may be water quenching, and further the mass ratio of water to the compound 28 is 5:1; the separation may be filtration; (13) The raw materials and reagents of the method for preparing compound 30 are composed of the following components: the solvent, the base, the catalyst, the phase transfer catalyst, the compound 28 and the compound 29.

6. A method 2 for preparing compound 31, characterized in that: The method comprises the following steps: in a solvent, in the presence of a base and a catalyst, compound 28 reacts with compound 29 to obtain compound 31, wherein the base is an alkali metal carbonate; the catalyst is a halogen metal salt; 7. The preparation method 2 of compound 31 according to claim 6, characterized in that: It meets one or more of the following conditions: (1) The solvent is a polar aprotic solvent, for example, one or more selected from amide solvents, sulfoxide solvents, nitrile solvents, ketone solvents and ester solvents; the amide solvent may be N,N-dimethylformamide; the sulfoxide solvent may be dimethyl sulfoxide; the nitrile solvent may be acetonitrile; the ketone solvent may be acetone; the ester solvent may be ethyl acetate; the solvent is preferably DMF; (2) The mass ratio of the compound 28 to the solvent is 1:(1-10), for example 1:5; (3) The base is an alkali metal carbonate, an alkali metal hydroxide and an organic base. The alkali metal carbonate may be potassium carbonate and / or sodium carbonate; the alkali metal hydroxide may be sodium hydroxide and / or potassium hydroxide; the organic base may be triethylamine; and the base is more preferably anhydrous potassium carbonate; (4) The molar ratio of the compound 28 to the base is 1:(1-3), for example 1:1.2; (5) The halogen metal salt is an alkali metal salt, preferably potassium iodide and / or potassium bromide, such as potassium iodide; (6) The molar ratio of the compound 28 to the catalyst is 1:(0.05-0.3), for example 1:0.1; (7) The molar ratio of the compound 28 to the compound 29 is 1:(1-2.5), for example 1:1.03; The preparation method 2 of the compound 31 comprises the following steps: compound 28 is subjected to step 1 to obtain compound 30, and then subjected to step 2 to obtain compound 31. Preferably, the preparation method 2 of compound 31 satisfies one or more of the following conditions: (1) The reaction temperature of step 1 is 70° C. to 130° C., preferably 80° C. to 110° C., for example 110° C.; (2) The reaction time of step 1 is 1-24 hours, for example 2 hours; (3) Between step 1 and step 2, a dehydration operation is further included; the dehydration includes physical dehydration and chemical dehydration; (4) The reaction temperature of step 2 is 135°C to 180°C, preferably 140°C to 160°C; for example 150°C; (5) The reaction time of step 2 is 1-24 hours, for example 3-6 hours, for example 5 hours; (6) After step 2, water is further added, and the molar ratio of water to compound 28 is greater than or equal to 1, preferably the molar ratio of water to compound 28 is 2.08:1; (7) The preparation method 2 of compound 31 may further include post-treatment, wherein the post-treatment steps and operations are as described in claim 2 or 3; (8) The raw materials and reagents of the preparation method 2 of the compound 31 consist of the following components: the solvent, the base, the catalyst and the compound 28.

8. A method for preparing compound 1, characterized in that: The method comprises the following steps: in a solvent, compound 31 and N-methyl-o-phenylenediamine or N-methyl-o-phenylenediamine salt undergo a ring-closing reaction to obtain compound 1; 9. The method for preparing compound 1 according to claim 8, characterized in that: It meets one or more of the following conditions: (1) The solvent is selected from one or more of amide solvents, sulfoxide solvents, alkane solvents, alcohol solvents, nitrile solvents, ester solvents, aromatic hydrocarbon solvents, halogenated hydrocarbon solvents and ether solvents; the amide solvent may be N,N-dimethylformamide; the sulfoxide solvent may be dimethyl sulfoxide; the alkane solvent may be N-methylpyrrolidone and / or acetone; the alcohol solvent may be ethanol; the nitrile solvent may be acetonitrile; the ester solvent may be ethyl acetate; the aromatic hydrocarbon solvent may be toluene; the halogenated hydrocarbon solvent may be 1,2-dichloroethane; the ether solvent may be tetrahydrofuran; and the solvent is preferably DMF; (2) The mass ratio of the compound 31 to the solvent is 1:(1-10), for example 1:5; (3) The N-methyl-o-phenylenediamine salt is further preferably N-methyl-o-phenylenediamine hydrochloride; (4) The molar ratio of the compound 31 to the N-methyl-o-phenylenediamine or its salt is 1:(0.8-1.2), for example 1:1; (5) The ring-closing reaction includes a base; (7) The ring-closing reaction includes an additive; (8) The preparation method of compound 1 further comprises post-treatment, wherein the post-treatment operation comprises the following steps: cooling, quenching, extraction, concentration, and purification after the ring-closure reaction is completed; (9) The raw materials and reagents of the preparation method of the compound 1 are composed of the following components: the solvent, the compound 31 and the N-methyl-o-phenylenediamine or its salt; (10) The method for preparing compound 1 further comprises the following steps: Preparation method 1 of compound 31 comprises the following steps: in a solvent, in the presence of a base, compound 30 undergoes an amino reaction as shown in the following formula to obtain compound 31, wherein the base is an alkali metal carbonate; Alternatively, the preparation method 2 of compound 31 comprises the following steps: in a solvent, in the presence of a base and a catalyst, compound 28 reacts with compound 29 to obtain compound 31, wherein the base is an alkali metal carbonate; the catalyst is a halogen metal salt and / or a phase transfer catalyst; Preferably, the method for preparing compound 1 satisfies one or more of the following conditions: (1) The additive is an alkali metal hydrogen sulfate; the alkali metal hydrogen sulfate may be sodium bisulfite and / or sodium trisulfite; more preferably sodium bisulfite; (2) The base is an organic base and / or an inorganic base; the organic base may be triethylamine; the base is preferably triethylamine; (3) The molar ratio of the N-methyl-o-phenylenediamine or its salt to the base is 1:(1-3), for example 1:2.05; (4) The molar ratio of the compound 31 to the additive is 1:(1-2), for example 1:1.2; (5) The temperature of the ring-closing reaction is 60°C to 130°C, preferably 70°C to 130°C, such as 70, 80, 90, 110 or 130°C, preferably 130°C; (6) The reaction time of the ring-closure reaction is 1-24 hours, for example 3-6 hours, and for example 5 hours; (7) The reaction conditions and steps of the preparation method 1 of compound 31 are as described in any one of claims 1 to 5; (8) The reaction conditions and steps described in method 2 for preparing compound 31 are as described in claim 6 or 7.

10. A method for preparing compound 30, characterized in that: The method comprises the following steps: in a solvent, in the presence of a base, a catalyst and a phase transfer catalyst, compound 28 undergoes an alkylation reaction with chloroacetamide to obtain compound 30; The reaction conditions and steps of the preparation method of compound 30 are as described in claim 4 or 5.

11. A compound 30, whose structure is shown below:

Citation Information

Patent Citations

  • New method for synthesizing telmisartan intermediates

    CN102229570A

  • Drug intermediate compound as well as preparation method and application thereof

    CN113024399A

  • Synthesis method of telmisartan intermediate

    CN113024469A

  • Synthesis method of o-tert-butyl aniline

    CN114773206A

  • Process for making 1,4-diamino-2-methoxymethylbenzene and salts thereof and compositions and methods for dyeing keratin fibers containing same

    US20030041392A1